Although metabolic studies have been employed in mice lacking TDAG51 in all cell types and tissues, the purpose of this study was to directly investigate the potential role of enhancing hepatocyte-specific TDAG51 levels, its impact on extrahepatic tissues and related outcomes in the context of obesity and IR. The gene discussed is PHLDA1; the disease is Obesity.